<DOC>
	<DOCNO>NCT02544074</DOCNO>
	<brief_summary>The Self-Administered Gerocognitive Examination ( SAGE ) valid reliable cognitive assessment tool use identify Mild Cognitive Impairment ( MCI ) early dementia . SAGE 's self-administered feature , pen paper format , four equivalent interchangeable form allow give almost setting , require staff time administer make practical rapidly screen large number individual community home.This trial conduct study validity SAGE digital format ( eSAGE ) cognitive screening . The investigator analyze data learn correlation eSAGE gold standard neuropsychological testing design differentiate normal cognition MCI early dementia . The investigator also find whether paper ( SAGE ) electronic ( eSAGE ) version SAGE could use interchangeably .</brief_summary>
	<brief_title>Validity Electronic Self-Administered Gerocognitive Examination ( eSAGE )</brief_title>
	<detailed_description>Participants recruit base eSAGE score evaluate neuropsychological test medical history determine status normal , mild cognitive impairment , dementia . The investigator analyze data learn correlation eSAGE gold standard neuropsychological testing design differentiate normal cognition MCI early dementia . The investigator also find whether paper ( SAGE ) electronic ( eSAGE ) version SAGE could use interchangeably .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Adults 49 year old either gender Vision hearing sufficient compliance test Diagnosis physician moderate severe dementia Intellectual disability</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>